BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blanco VM, Chu Z, LaSance K, Gray BD, Pak KY, Rider T, Greis KD, Qi X. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles. Oncotarget 2016;7:32866-75. [PMID: 27096954 DOI: 10.18632/oncotarget.8763] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Kaynak A, Davis HW, Kogan AB, Lee J, Narmoneva DA, Qi X. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy. Cancers 2022;14:2536. [DOI: 10.3390/cancers14102536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kubeil M, Martínez IIS, Bachmann M, Kopka K, Tuck KL, Stephan H. Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives. Pharmaceuticals 2022;15:432. [DOI: 10.3390/ph15040432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ariztia J, Solmont K, Moïse NP, Specklin S, Heck MP, Lamandé-Langle S, Kuhnast B. PET/Fluorescence Imaging: An Overview of the Chemical Strategies to Build Dual Imaging Tools. Bioconjug Chem 2022. [PMID: 34994545 DOI: 10.1021/acs.bioconjchem.1c00503] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
4 Kaynak A, Davis HW, Vallabhapurapu SD, Pak KY, Gray BD, Qi X. SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals (Basel) 2021;14:1193. [PMID: 34832975 DOI: 10.3390/ph14111193] [Reference Citation Analysis]
5 Tripathi SK, Kean R, Bongiorno E, Hooper DC, Jin YY, Wickstrom E, McCue PA, Thakur ML. Targeting VPAC1 Receptors for Imaging Glioblastoma. Mol Imaging Biol 2020;22:293-302. [PMID: 31292914 DOI: 10.1007/s11307-019-01388-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Chaudhari P. Preclinical Imaging for Laboratory Rodents. Essentials of Laboratory Animal Science: Principles and Practices 2021. [DOI: 10.1007/978-981-16-0987-9_25] [Reference Citation Analysis]
7 Davis HW, Vallabhapurapu SD, Chu Z, Wyder MA, Greis KD, Fannin V, Sun Y, Desai PB, Pak KY, Gray BD, Qi X. Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles. Cells. 2020;9. [PMID: 32854321 DOI: 10.3390/cells9091960] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 N'Guessan KF, Patel PH, Qi X. SapC-DOPS - a Phosphatidylserine-targeted Nanovesicle for selective Cancer therapy. Cell Commun Signal 2020;18:6. [PMID: 31918715 DOI: 10.1186/s12964-019-0476-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
9 Burke BP, Cawthorne C, Archibald SJ. Multimodal nanoparticle imaging agents: design and applications. Philos Trans A Math Phys Eng Sci 2017;375:20170261. [PMID: 29038384 DOI: 10.1098/rsta.2017.0261] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
10 Liu H, Liu Y, Man F, Liu G. Overcoming the Physiopathologic Barriers: Nanoprobes-Mediated Intracranial Glioma Imaging. Nanomedicine in Brain Diseases 2019. [DOI: 10.1007/978-981-13-8731-9_5] [Reference Citation Analysis]
11 Alphandéry E. Glioblastoma Treatments: An Account of Recent Industrial Developments. Front Pharmacol 2018;9:879. [PMID: 30271342 DOI: 10.3389/fphar.2018.00879] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 14.0] [Reference Citation Analysis]
12 Varani M, Galli F, Auletta S, Signore A. Radiolabelled nanoparticles for cancer diagnosis. Clin Transl Imaging 2018;6:271-92. [DOI: 10.1007/s40336-018-0283-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
13 He Z, Zhang X, Huang J, Wu Y, Huang X, Chen J, Xia J, Jiang H, Ma J, Wu J. Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc. Oncotarget 2016;7:76635-46. [PMID: 27791199 DOI: 10.18632/oncotarget.12850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
14 Dukleska K, Yeo CJ, Pishvaian MJ, Brody JR. Precision Medicine Based on Next Generation Sequencing and Master Controllers. Pancreatic Cancer 2018. [DOI: 10.1007/978-1-4939-6631-8_71-1] [Reference Citation Analysis]
15 Setua S, Jaggi M, Yallapu MM, Chauhan SC, Danilushkina A, Lee H, Choi IS, Fakhrullin R, Esposti LD, Tampieri A, Iafisco M, Shevtsov M, Multhoff G. Targeted and theranostic applications for nanotechnologies in medicine. Nanotechnologies in Preventive and Regenerative Medicine 2018. [DOI: 10.1016/b978-0-323-48063-5.00006-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
16 Davis HW, Hussain N, Qi X. Detection of cancer cells using SapC-DOPS nanovesicles. Mol Cancer 2016;15:33. [PMID: 27160923 DOI: 10.1186/s12943-016-0519-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]